11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with Innate Inflammatory Response in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheu, RK; Collier, AC; Coronado, E; Funderburg, NT; Gott, TM; Hensley-McBain, T; Hunt, PW; Isoherranen, N; Kirkwood, JS; Klatt, NR; Manuzak, JA; Martin, JN; Miller, C; Wu, MC | 1 |
1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and Innate Inflammatory Response
Article | Year |
---|---|
Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dronabinol; Female; Flow Cytometry; HIV Infections; Humans; Immunity, Innate; Inflammation; Lymphocyte Activation; Male; Marijuana Abuse; Middle Aged; Monocytes; Viral Load | 2018 |